78 /100
CRITICAL RISK
Score updated May 16, 2026

UPXI — Upexi, Inc. Dilution Risk Tracker

Track UPXI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track UPXI — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
95
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
55%
🔁 Convertible Conversion 60%
• Major convertible overhang: 178% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise 55%
• Critical: only 0.2 months cash remaining
🔄 Reverse Split 45%
• 50-day avg $1.20 approaching $1 threshold
• Only 0 months cash — financial pressure
🔔 Track UPXI — Get forecast alerts →

💹 Market Data

Market Cap$101.88M
Shares Outstanding70.26M
Float65.55M
Cash$3.48M
Debt$242.80M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 12.8% shares (2025Q4 vs prior)
69 institutional holders · 27.43M shares
#1 Polar Asset Management Partners Inc. 5.20M shares
#2 Arrington Capital Management, LLC 2.76M shares
#3 Marex Group plc 2.51M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest18.19M
Days to Cover5.9
% of Float27.8%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Mar 31, 2026
xbrl XBRL WARRANT Jun 30, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track UPXI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking UPXI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for UPXI
📊 UPXI FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 UPXI Signal Convergence & Dark Pool Activity — StonkWhisper 📄 UPXI Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.